The Latest Breaking News from HIV

Eight months into Donald Trump’s second presidency of the United States, truth and science are again under attack – with global consequences. USAID, which tackled HIV, TB, malaria and child malnutrition is gone. Funding has been withdrawn from GAVI, a public–private global alliance that helps buy vaccines for the world’s…

A Hospice UK report released in 2023 found that end of life care received by trans and gender diverse people was usually not inclusive

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health Organization

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health

In June, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s (NASDAQ:GILD) Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice-yearly option available in the U.S. for people who need or…

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV

The drug is expected to be formally approved by the European Commission this year.

My phone wouldn’t stop ringing – nurses, social workers, young mothers – all begging for help. ‘I’ve lost my job,’ ‘I have no food,’ ‘What do we do now?’ I felt helpless.

The US Senate votes to keep money for the President’s Emergency Plan for Aids Relief from a package of more than $9 billion in cuts going through Congress

The move to save PEPFAR funding may prove useful in rallying GOP support from powerful lawmakers like Senate Appropriations chair Susan Collins, an outspoken critic of Trump’s proposed cuts.